FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Appeals Court Backs FDAs Sameness Interpretation

An appeals court rules for FDA that a clinically superior drug is not the same as a drug that is otherwise the same.

latest-news-card-1
Human Drugs

NDA Filed for Nicotine Dependence Drug

Achieve Life Sciences files an NDA for cytisinicline for treating nicotine dependence as part of smoking cessation in adults.

latest-news-card-1
Human Drugs

Livmarli, Bylvay Get Liver Injury/Bleeding Updates

FDA issues safety-related labeling updates for two bile acid transport inhibitors Mirum Pharmaceuticals Livmarli and Ipsen Biopharmaceuticals Bylvay ...

Human Drugs

Antibacterial Therapies Development Q&A Guidance

FDA publishes a question-and-answer guidance to help sponsors develop new antibacterial drugs.

latest-news-card-1
Human Drugs

Altimmune Mixed Results for Pemvidutide in MASH

Altimmune reports mixed topline results today from its Phase 2b IMPACT trial evaluating pemvidutide in patients with metabolic dysfunction-associated ...

latest-news-card-1
Medical Devices

UDI Requirements for Combo Products Guide

FDA posts a draft guidance entitled Unique Device Identifier (UDI) Requirements for Combination Products.

latest-news-card-1
Biologics

Marks: Why Dramatic Departure from Vaccine Policy?

Former CBER director Peter Marks says FDA should explain why it changed its Covid-19 vaccine policy in a way that did not promote transparency and gol...

latest-news-card-1

Remote Regulatory Assessment Q&A Guidance

FDA publishes a guidance with questions and answers on its various remote regulatory assessment tools.

latest-news-card-1
Medical Devices

Device Cybersecurity Quality System Consideration Guide

FDA posts a final guidance entitled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.

latest-news-card-1
Human Drugs

FDA RMAT Designation for Detalimogene

FDA grants regenerative medicine advanced therapy designation for enGene Holdings bladder cancer drug detalimogene.